Cambrex Expands Services with a New Storage Facility
Cambrex, a prominent name in contract development and manufacturing, has recently opened a state-of-the-art cGMP stability storage facility powered by Q1 Scientific. This facility significantly enhances their capacity to provide environmentally controlled stability storage services that cater to pharmaceutical, medical device, and life sciences industries.
Strategic Location for Maximized Efficiency
Positioned strategically in a hub known for innovation, the cutting-edge storage facility includes seven ICH stability chambers. These chambers are versatile, providing specific conditions such as 2-8°C, 25°C/60%RH, and even ultra-low storage options at -70°C/-80°C. Its location allows the team to offer same-day and next-day delivery options, responding promptly to client needs throughout the continent.
A Milestone in Growth
Tom Loewald, Cambrex's CEO, expressed excitement regarding this new opening. Since acquiring Q1 Scientific, the company has worked diligently to broaden its reach and capabilities, marking a significant step in their growth strategy with this North American facility.
Complementary Services for Enhanced Client Support
Q1 Scientific's new storage facility in North America complements their existing operations in other regions. By being co-located with Cambrex's analytical services site, they can now offer a more comprehensive suite of services, including stability testing and other vital analytical services that support both clinical and commercial needs.
A Response to Industry Demands
As the demand for outsourced drug development and manufacturing continues to grow, Cambrex is committed to expanding its network of capabilities across North America and Europe. This new facility is a testament to their dedication to addressing the needs of the pharmaceutical industry.
About Cambrex
With a legacy of over four decades, Cambrex has established itself as a leader in contract development and manufacturing organization (CDMO) services. They specialize in every stage of the drug lifecycle, offering extensive analytical and IND enabling services. Their team of around 2,000 professionals works tirelessly to ensure clients receive specialized technologies and capabilities, facilitating the development of essential pharmaceuticals.
About Q1 Scientific
Q1 Scientific offers control over drug substances and is a trusted partner for companies engaged in innovative medical solutions. It is recognized for its ability to provide stability storage optimized for the pharmaceutical sector, which safeguards critical breakthroughs. Their expansions beyond Ireland and Belgium showcase their commitment to enhancing client offerings, alongside Cambrex’s support.
Frequently Asked Questions
What is the purpose of Cambrex's new facility?
The facility is designed to provide advanced stability storage services for the pharmaceutical and life sciences sectors, enhancing Cambrex's capabilities.
Where is the new Cambrex facility located?
The new facility is strategically located in a major innovation hub, enhancing operational efficiency and service delivery.
What services does Q1 Scientific offer?
Q1 Scientific specializes in environmentally controlled stability storage, stability testing, and analytical services for clinical products.
Who leads Cambrex as CEO?
Tom Loewald serves as the CEO, focusing on continual expansion and client service improvement across the organization.
How does Cambrex respond to market demands?
Cambrex actively expands its network and resources, positioning itself to meet the surging demands for drug development and manufacturing outsourcing.
